Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anne M. Yahanda"'
Autor:
Branimir I. Sikic, Sonja Kaubisch, N A Brophy, Kent M. Adler, George A. Fisher, Bert L. Lum, Anne M. Yahanda, Joanne Halsey
Publikováno v:
Cancer. 72:3502-3514
A growing body of evidence indicates that expression of the mdr1 gene, which encodes the multidrug transporter, P-glycoprotein, contributes to chemotherapeutic resistance of human cancers. Expression of this protein in normal tissues such as the bili
Autor:
Lyle Jew, Mohamed N. Ehsan, N A Brophy, Sonia Kaubisch, Michael P. Gosland, Bert L. Lum, Joanne Halsey, Kent M. Adler, Anne M. Yahanda, Branimir I. Sikic
Publikováno v:
Journal of Clinical Oncology. 10:1635-1642
PURPOSE To determine the effects of high-dose cyclosporine (CsA) infusion on the pharmacokinetics of etoposide in patients with cancer. PATIENTS AND METHODS Sixteen patients were administered 20 paired courses of etoposide and CsA/etoposide. Etoposid
Autor:
N A Brophy, Bert L. Lum, Joanne Halsey, Anne M. Yahanda, George A. Fisher, Michael P. Gosland, K M Alder, R I Hardy, Branimir I. Sikic
Publikováno v:
Journal of Clinical Oncology. 10:1624-1634
PURPOSE To determine the maximum-tolerated dose (MTD) of cyclosporine (CsA) infusion administered with etoposide for 3 days in patients with cancer. PATIENTS AND METHODS Of the 72 registered patients, 26 were treated initially with CsA and etoposide.
Autor:
Bert L. Lum, George A. Fisher, N A Brophy, Branimir I. Sikic, Anne M. Yahanda, Kent M. Adler, Joanne Halsey
Publikováno v:
Anticancer Drug Resistance ISBN: 9781461361299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd1574289018d6c6d70c71b534c84504
https://doi.org/10.1007/978-1-4615-2632-2_8
https://doi.org/10.1007/978-1-4615-2632-2_8
Autor:
Anne M. Yahanda, Martha Vincent, Vincent J. Picozzi, John Grous, Imad A. Tabbara, John A. Glaspy, David H. Johnson, Roy E. Smith, Morgan Stewart, Ronald G. Stoller, Jeffrey Crawford, William J. Gradishar, Howard Ozer, Gregory Rausch, Mark G. Kris, Gary H. Lyman
Publikováno v:
The New England journal of medicine. 325(3)
Neutropenia and infection are major dose-limiting side effects of chemotherapy. Previous studies have suggested that recombinant methionyl granulocyte colony-stimulating factor (G-CSF) can reduce chemotherapy-related neutropenia in patients with canc